The phrase "ad agitation" is not correct and does not appear to be a standard expression in written English.
It seems to be an attempt to convey a concept related to agitation, but without proper context or clarity, it is not usable.
Example: "The constant noise led to a state of ad agitation, making it difficult to concentrate."
Alternatives: "to agitation" or "toward agitation".
While nearly half of all people with Alzheimer's disease (AD) have agitation symptoms every month, little is known about the costs of agitation in AD.
Among the four trials, a smaller trial chose nursing home patients with AD and agitation and compared quetiapine treatment with rivastigmine and placebo [ 26].
Adding to her agitation was the fact that a fireman had told her, incorrectly, that the water in Concord Bridge was expected to rise another three feet overnight.
Adding to the agitation, neither team has been a runaway success on the field, making it harder for fans to justify paying so much more for tickets.
Adding to the agitation within the Obama administration is the presence in the Kuwaiti cabinet of a figure who U.S. officials charge is a major terror financier.
Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD) Cohen-Mansfield Agitation Inventory (CMAI) Exploratory Factor Analysis (EFA) Mini-Mental Status Exam (MMSE) Modified Strain in Nursing Care Assessment Scale (M-NCAS) Strain in Nursing Care Assessment Scale (NCAS) LK participated in the data analysis design, data interpretation, and drafting of the manuscript.
There is no previous evidence about the cost of agitation in AD, even though nearly half of all people with AD have agitation symptoms every month; this study calculated that the mean excess cost associated with agitation per person with AD was £4091 a year.
Teri, L. et al. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.
Health economic analyses of interventions for reducing agitation in AD incorporated into clinical trials are needed.
In this study of over 300 AD patients with significant agitation at baseline, there were no differences on any of the neuropsychiatric outcome measures compared with placebo.
